These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 17136296

  • 1. Inhaled corticosteroids in the treatment of respiratory allergy: safety vs. efficacy.
    Rizzo MC, Solé D.
    J Pediatr (Rio J); 2006 Nov; 82(5 Suppl):S198-205. PubMed ID: 17136296
    [Abstract] [Full Text] [Related]

  • 2. Ciclesonide versus other inhaled corticosteroids for chronic asthma in children.
    Kramer S, Rottier BL, Scholten RJ, Boluyt N.
    Cochrane Database Syst Rev; 2013 Feb 28; (2):CD010352. PubMed ID: 23450613
    [Abstract] [Full Text] [Related]

  • 3. Inhaled corticosteroids in children with persistent asthma: effects of different drugs and delivery devices on growth.
    Axelsson I, Naumburg E, Prietsch SO, Zhang L.
    Cochrane Database Syst Rev; 2019 Jun 10; 6(6):CD010126. PubMed ID: 31194879
    [Abstract] [Full Text] [Related]

  • 4. Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review.
    Dyer MJ, Halpin DM, Stein K.
    BMC Fam Pract; 2006 Jun 05; 7():34. PubMed ID: 16753053
    [Abstract] [Full Text] [Related]

  • 5. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma].
    Bartkowiak-Emeryk M, Breborowicz A, Emeryk A, Kulus M, Kurzawa R, Lis G, Mazurek H, Niedziela M.
    Pol Merkur Lekarski; 2004 Jun 05; 17 Suppl 2():5-10. PubMed ID: 15688663
    [Abstract] [Full Text] [Related]

  • 6. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.
    Chauhan BF, Chartrand C, Ducharme FM.
    Cochrane Database Syst Rev; 2012 Dec 12; 12():CD009611. PubMed ID: 23235678
    [Abstract] [Full Text] [Related]

  • 7. Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic review.
    Richy F, Bousquet J, Ehrlich GE, Meunier PJ, Israel E, Morii H, Devogelaer JP, Peel N, Haim M, Bruyere O, Reginster JY.
    Osteoporos Int; 2003 May 12; 14(3):179-90. PubMed ID: 12730758
    [Abstract] [Full Text] [Related]

  • 8. Ciclesonide: a novel inhaled corticosteroid.
    Humbert M.
    Expert Opin Investig Drugs; 2004 Oct 12; 13(10):1349-60. PubMed ID: 15461563
    [Abstract] [Full Text] [Related]

  • 9. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis.
    Lipworth BJ.
    Arch Intern Med; 1999 May 10; 159(9):941-55. PubMed ID: 10326936
    [Abstract] [Full Text] [Related]

  • 10. Impact of long-term inhaled corticosteroid therapy on bone mineral density: results of a meta-analysis.
    Halpern MT, Schmier JK, Van Kerkhove MD, Watkins M, Kalberg CJ.
    Ann Allergy Asthma Immunol; 2004 Feb 10; 92(2):201-7; quiz 207-8, 267. PubMed ID: 14989387
    [Abstract] [Full Text] [Related]

  • 11. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
    Greenstone IR, Ni Chroinin MN, Masse V, Danish A, Magdalinos H, Zhang X, Ducharme FM.
    Cochrane Database Syst Rev; 2005 Oct 19; (4):CD005533. PubMed ID: 16235409
    [Abstract] [Full Text] [Related]

  • 12. Inhaled corticosteroids in children with asthma: pharmacologic determinants of safety and efficacy and other clinical considerations.
    Gulliver T, Morton R, Eid N.
    Paediatr Drugs; 2007 Oct 19; 9(3):185-94. PubMed ID: 17523699
    [Abstract] [Full Text] [Related]

  • 13. Inhaled corticosteroids in children with persistent asthma: effects on growth.
    Zhang L, Prietsch SO, Ducharme FM.
    Evid Based Child Health; 2014 Dec 19; 9(4):829-930. PubMed ID: 25504972
    [Abstract] [Full Text] [Related]

  • 14. Safety of the newer inhaled corticosteroids in childhood asthma.
    Randell TL, Donaghue KC, Ambler GR, Cowell CT, Fitzgerald DA, van Asperen PP.
    Paediatr Drugs; 2003 Dec 19; 5(7):481-504. PubMed ID: 12837120
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological Basis of Differences in Dose Response, Dose Equivalence, and Duration of Action of Inhaled Corticosteroids.
    Daley-Yates PT, Aggarwal B, Plank M.
    Adv Ther; 2024 May 19; 41(5):1995-2009. PubMed ID: 38532238
    [Abstract] [Full Text] [Related]

  • 16. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
    Frois C, Wu EQ, Ray S, Colice GL.
    Clin Ther; 2009 Dec 19; 31(12):2779-803. PubMed ID: 20110019
    [Abstract] [Full Text] [Related]

  • 17. [Inhaled corticosteroids: first-line therapy in asthma].
    Hajiro T, Ishihara K.
    Nihon Rinsho; 2001 Oct 19; 59(10):1967-72. PubMed ID: 11676140
    [Abstract] [Full Text] [Related]

  • 18. The properties of inhaled corticosteroids: similarities and differences.
    Barnes NC.
    Prim Care Respir J; 2007 Jun 19; 16(3):149-54. PubMed ID: 17530144
    [Abstract] [Full Text] [Related]

  • 19. Pharmacologic characteristics and adrenal suppression with newer inhaled corticosteroids: A comparison of ciclesonide and fluticasone propionate.
    Kaliner MA.
    Clin Ther; 2006 Mar 19; 28(3):319-31. PubMed ID: 16750447
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of inhaled corticosteroids relative to fluticasone propionate: a systematic review of randomized controlled trials in asthma.
    Yeo SH, Aggarwal B, Shantakumar S, Mulgirigama A, Daley-Yates P.
    Expert Rev Respir Med; 2017 Oct 19; 11(10):763-778. PubMed ID: 28752776
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.